In addition to its robust safety, the drug has 3 unique characteristics that deeply matter to PV-10's proposition and make it so broadly efficacious:
- Delivery mechanism: Intra-tumoral injection,
- Multiple targeting: A full expression of antigens in context, and
- Tissue specificity: Destruction only of diseased tissue
Some context: PV-10's immunologic mechanism of action lies in a separate category than, say, Provenge. Provectus' drug triggers an internal vaccination (internal antigenization), while Provenge operates on the basis of an external vaccination (with very marginal efficacy).